The Israel Institute for Biological Research (IIBR)'s scientists said that an antibody formula against the COVID-19 has been patented.
IIBR in its press release said that a platform has been well established for antibody engineering and had managed to isolate monoclonal antibodies against viruses. IIBR is first to demonstrate that the antibody that was isolated from the COVID-19 patients can counterpoise the virus. It also said that they would mass produce it for clinical use.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.